Marilda Beqiri

2.3k total citations · 1 hit paper
6 papers, 945 citations indexed

About

Marilda Beqiri is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marilda Beqiri has authored 6 papers receiving a total of 945 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Molecular Biology and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Marilda Beqiri's work include CAR-T cell therapy research (3 papers), CRISPR and Genetic Engineering (2 papers) and Cancer Cells and Metastasis (2 papers). Marilda Beqiri is often cited by papers focused on CAR-T cell therapy research (3 papers), CRISPR and Genetic Engineering (2 papers) and Cancer Cells and Metastasis (2 papers). Marilda Beqiri collaborates with scholars based in United States, Australia and Germany. Marilda Beqiri's co-authors include Meenhard Herlyn, Katherine L. Nathanson, Ioannis N. Anastopoulos, Clemens Krepler, Abhyudai Singh, Eduardo A. Torre, Cesar A. Vargas-García, Benjamin Emert, Stefan Torborg and Min Xiao and has published in prestigious journals such as Nature, Blood and Journal of Investigative Dermatology.

In The Last Decade

Marilda Beqiri

6 papers receiving 937 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

2017 756 citations Sydney M. Shaffer, Margaret C. Dunagin et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marilda Beqiri United States	5	658	354	211	153	120	6	945
Katrin Sproesser United States	8	935 1.4×	450 1.3×	223 1.1×	180 1.2×	71 0.6×	16	1.2k
Robert Cornelison United States	18	770 1.2×	297 0.8×	230 1.1×	114 0.7×	115 1.0×	29	1.1k
Veronique Neumeister United States	17	510 0.8×	496 1.4×	319 1.5×	92 0.6×	170 1.4×	35	968
Ella Kim Germany	21	833 1.3×	607 1.7×	206 1.0×	62 0.4×	98 0.8×	38	1.2k
Erin McCaffrey United States	8	544 0.8×	175 0.5×	161 0.8×	181 1.2×	243 2.0×	19	877
Marco Piva United States	10	748 1.1×	616 1.7×	202 1.0×	214 1.4×	90 0.8×	13	1.1k
Steve Lianoglou United States	10	814 1.2×	346 1.0×	246 1.2×	306 2.0×	80 0.7×	11	1.3k
Aislyn Schalck United States	5	533 0.8×	322 0.9×	405 1.9×	158 1.0×	112 0.9×	7	794
Reuben Moncada United States	4	791 1.2×	318 0.9×	339 1.6×	292 1.9×	75 0.6×	7	1.1k
Stefan Torborg United States	4	632 1.0×	273 0.8×	219 1.0×	110 0.7×	56 0.5×	6	837

Countries citing papers authored by Marilda Beqiri

Since Specialization

Citations

This map shows the geographic impact of Marilda Beqiri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marilda Beqiri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marilda Beqiri more than expected).

Fields of papers citing papers by Marilda Beqiri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marilda Beqiri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marilda Beqiri. The network helps show where Marilda Beqiri may publish in the future.

Co-authorship network of co-authors of Marilda Beqiri

This figure shows the co-authorship network connecting the top 25 collaborators of Marilda Beqiri. A scholar is included among the top collaborators of Marilda Beqiri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marilda Beqiri. Marilda Beqiri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Campion, Liam, Katherine E. Santostefano, Toshinobu Nishimura, et al.. (2022). 262 Multiple targeting of solid tumors with iPSC-derived gamma delta CAR T cells in combination with therapeutic antibodies. Regular and Young Investigator Award Abstracts. A277–A277. 2 indexed citations

2.

Borges, Luís, Mark A. Wallet, Michael Naso, et al.. (2021). Development of Multi-Engineered iPSC-Derived CAR-NK Cells for the Treatment of B-Cell Malignancies. Blood. 138(Supplement 1). 1729–1729. 6 indexed citations

3.

Wallet, Mark A., Toshinobu Nishimura, Andriana Lebid, et al.. (2021). Induced Pluripotent Stem Cell-Derived Gamma Delta CAR-T Cells for Cancer Immunotherapy. Blood. 138(Supplement 1). 2771–2771. 19 indexed citations

4.

Vijayaraghavan, Smruthi, Lorraine Lipfert, Kristen Chevalier, et al.. (2020). Amivantamab (JNJ-61186372), an Fc Enhanced EGFR/cMet Bispecific Antibody, Induces Receptor Downmodulation and Antitumor Activity by Monocyte/Macrophage Trogocytosis. Molecular Cancer Therapeutics. 19(10). 2044–2056. 138 indexed citations

5.

Heppt, Markus V., Joshua X. Wang, Denitsa M. Hristova, et al.. (2017). MSX1-Induced Neural Crest-Like Reprogramming Promotes Melanoma Progression. Journal of Investigative Dermatology. 138(1). 141–149. 24 indexed citations

6.

Shaffer, Sydney M., Margaret C. Dunagin, Stefan Torborg, et al.. (2017). Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 546(7658). 431–435. 756 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact